Chargement en cours...
Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
Provision of high-level healthcare is a challenge for all low- to middle-income countries (LMICs) since healthcare systems are heterogeneous, face many challenges such as inadequate funding, inequitable distribution of resources and services and usually are not adequately equipped to deal with a hug...
Enregistré dans:
| Publié dans: | Ecancermedicalscience |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Cancer Intelligence
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6372298/ https://ncbi.nlm.nih.gov/pubmed/30792815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2019.898 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|